Santé Ventures related stories
All articles and analysis
Molecular Templates grabs $3.5 mln Series CMolecular Templates has secured an additional $3.5 million in Series C funding from AJU IB Investment. In conjunction with the funding, Timothy Sullivan, a partner at AJU Life Sciences Overseas Expansion Platform Fund, has been added to the firm's board of directors. Based in Georgetown, Texas, Molecular Templates is a biopharmaceutical firm that focuses on developing the next generation of immunotoxins.
- Lumos Pharma raises $14 mln in Series A funding
Lumos Pharma, an early stage biopharmaceutical company, has raised $14 million in Series A funding. The round was co-led by Sante Ventures and New Enterprise Associates.
- VC-backed Molecular Templates garners $8.5 mln in Series C financing
Molecular Templates said Tuesday that it has raised $8.5 million in Series C financing. Excel Venture Management was the lead investor. Existing investor Santé Ventures also participated in the round. Concurrent with the funding, Excel's Dr. Steven Gullans and Caleb Winder join Molecular's board of directors. Based in Georgetown, Texas, Molecular Templates is a biopharmaceutical company focused on developing new biologic therapeutics.
- TVA Medical Raises $9.5 Mln
TVA Medical said Monday that raised $9.5 million in series B financing led by S3 Ventures. TriStar Technology Ventures and existing investor, Santé Ventures also participated. Austin-based TVA is a medical device company.
- Spinal Restoration Closes $5 Mln Debt, Equity Round
Spinal Restoration said Monday it closed a $5 million financing round, which includes $3 million equity from current investors Austin Ventures, Sante’ Ventures, and MB Venture Partners. Comerica Bank is also providing a $2 million debt facility. Austin-based Spinal Restoration is trying to gain regulatory approval of its Biostat System, a drug used to treat chronic disc pain.
- ChanRx Inks Series A
Cleveland-based ChanRx has closed on an undisclosed amount of Series A financing from investors including Sante Ventures. The company is developing drugs to treat atrial fibrillation. Sante Ventures was founded in 2006 and manages $260 million in capital.
- Slideshow: Top 10 Largest VC Funds Raised in Q1
As we reported earlier today /100782/giant-funds-from-bessemer-sequoia-and-kp-help-produce-biggest-quarter-for-vc-fundraising-since-q3-2008/ VC fundraising roared back in Q1, with U.S. VC funds raising their largest amount since the third quarter of 2008. Bessemer Venture Partners led the pack, raising a monster fund of $1.6 billion. Who else is in the top 10? Click through to check out our slideshow /100788/slideshow-top-10-largest-vc-funds-raised-in-q1/
- Explorys Raises $2.55 Million
Explorys Inc., a Cleveland-based provider of cloud computing solutions for healthcare data , has raised $2.55 million in Series B funding. Santé Ventures led the round, and was joined by return backer Cleveland Clinic Innovations
- EndoStim Raises $6 Million
EndoStim Inc., a St Louis-based developer of minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, has raised $6 million in Series B funding. Santé Ventures led the round, and was joined by Prolog Ventures, Vectis Healthcare & Life Sciences Fund and individual angels.